D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury

FASEB Journal

Volumn 27, Issue 6, 2013, Pages 2220-2232

  Miyahara, Takuya ^a   Runge, Sara ^a   Chatterjee, Anuran ^a   Chen, Mian ^a   Mottola, Giorgio ^a   Fitzgerald, Jonathan M ^b   Serhan, Charles N ^b   Conte, Michael S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Inflammation; Intracellular signaling; Resolving

Indexed keywords

ANTIINFLAMMATORY AGENT; FATTY ACID; LIPID; RESOLVIN; SUPEROXIDE; UNCLASSIFIED DRUG;

ANGIOPLASTY; ANIMAL TISSUE; ARTERY WALL; ARTICLE; BLOOD VESSEL INJURY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL RABBIT; FEMORAL ARTERY; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKOCYTE; MEDIATOR RELEASE; NEOINTIMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

INFLAMMATION; INTRACELLULAR SIGNALING; RESOLVIN;

ANIMALS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOCOSAHEXAENOIC ACIDS; FEMORAL ARTERY; HUMANS; INFLAMMATION MEDIATORS; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 84878759029     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-225615     Document Type: Article

References (43)

1. Hansson, G. K. (2005) Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-16955
2. Libby, P. (2002) Inflammation in atherosclerosis. Nature 420, 868-8744
3. Conte, M. S., Bandyk, D. F., Clowes, A. W., Moneta, G. L., Seely, L., Lorenz, T. J., Namini, H., Hamdan, A. D., Roddy, S. P., Belkin, M., Berceli, S. A., DeMasi, R. J., Samson, R. H., and Berman, S. S. (2006) Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J. Vasc. Surg. 43, 742-751; discussion 7511
4. Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., and Fowkes, F. G. (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J. Vasc. Surg. 45(Suppl. S), S5-S677
5. Rocha-Singh, K. J., Jaff, M. R., Crabtree, T. R., Bloch, D. A., and Ansel, G. (2007) Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc. Interv. 69, 910-9199
6. Schillinger, M., Sabeti, S., Dick, P., Amighi, J., Mlekusch, W., Schlager, O., Loewe, C., Cejna, M., Lammer, J., and Minar, E. (2007) Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115, 2745-27499
7. Serhan, C. N., and Savill, J. (2005) Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191-11977
8. Serhan, C. N. (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25, 101-1377
9. Serhan, C. N., Chiang, N., and Van Dyke, T. E. (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349-3611
10. Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., and Moussignac, R. L. (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025-10377
11. Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., and Gronert, K. (2000) Novel functional sets of lipidderived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192, 1197-12044
12. Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., and Serhan, C. N. (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287-12911
13. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., and Serhan, C. N. (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713-7222
14. Bannenberg, G. L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K. H., Hong, S., and Serhan, C. N. (2005) Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174, 4345-43555
15. Hong, S., Gronert, K., Devchand, P. R., Moussignac, R. L., and Serhan, C. N. (2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells: autacoids in anti-inflammation. J. Biol. Chem. 278, 14677-146877
16. Spite, M., Summers, L., Porter, T. F., Srivastava, S., Bhatnagar, A., and Serhan, C. N. (2009) Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. Br. J. Pharmacol. 158, 1062-10733
17. Sun, Y. P., Oh, S. F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S. P., Petasis, N. A., and Serhan, C. N. (2007) Resolvin D1 and its aspirin-triggered 17R epimer: stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282, 9323-93344
18. Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., Blumberg, R. S., and Serhan, C. N. (2005) Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. U. S. A. 102, 7671-76766
19. Bento, A. F., Claudino, R. F., Dutra, R. C., Marcon, R., and Calixto, J. B. (2011) Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J. Immunol. 187, 1957-19699
20. Connor, K. M., SanGiovanni, J. P., Lofqvist, C., Aderman, C. M., Chen, J., Higuchi, A., Hong, S., Pravda, E. A., Majchrzak, S., Carper, D., Hellstrom, A., Kang, J. X., Chew, E. Y., Salem, N., Jr., Serhan, C. N., and Smith, L. E. (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 13, 868-8733
21. Hasturk, H., Kantarci, A., Goguet-Surmenian, E., Blackwood, A., Andry, C., Serhan, C. N., and Van Dyke, T. E. (2007) Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J. Immunol. 179, 7021-70299
22. Hasturk, H., Kantarci, A., Ohira, T., Arita, M., Ebrahimi, N., Chiang, N., Petasis, N. A., Levy, B. D., Serhan, C. N., and Van Dyke, T. E. (2006) RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. FASEB J. 20, 401-4033
23. Merched, A. J., Ko, K., Gotlinger, K. H., Serhan, C. N., and Chan, L. (2008) Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 22, 3595-36066
24. Ho, K. J., Spite, M., Owens, C. D., Lancero, H., Kroemer, A. H., Pande, R., Creager, M. A., Serhan, C. N., and Conte, M. S. (2010) Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am. J. Pathol. 177, 2116-21233
25. Norling, L. V., Dalli, J., Flower, R. J., Serhan, C. N., and Perretti, M. (2012) Resolvin D1 limits polymorphonuclear leukocytes recruitment to inflammatory loci: receptor-dependent actions. Arterioscler. Thromb. Vasc. Biol. 32, 1970-19788
26. Filion, K. B., El Khoury, F., Bielinski, M., Schiller, I., Dendukuri, N., and Brophy, J. M. (2010) Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc. Disord. 10, 244
27. Wang, G. J., Sui, X. X., Simosa, H. F., Jain, M. K., Altieri, D. C., and Conte, M. S. (2005) Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein. Arterioscler. Thromb. Vasc. Biol. 25, 2081-20877
28. Ho, K. J., Owens, C. D., Longo, T., Sui, X. X., Ifantides, C., and Conte, M. S. (2008) C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta. Am. J. Physiol. Heart Circ. Physiol. 295, H1132-H11400
29. Patricia, M. K., Kim, J. A., Harper, C. M., Shih, P. T., Berliner, J. A., Natarajan, R., Nadler, J. L., and Hedrick, C. C. (1999) Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19, 2615-26222
30. Conte, M. S., Birinyi, L. K., Miyata, T., Fallon, J. T., Gold, H. K., Whittemore, A. D., and Mulligan, R. C. (1994) Efficient repopulation of denuded rabbit arteries with autologous genetically modified endothelial cells. Circulation 89, 2161-21699
31. Dalli, J., and Serhan, C. N. (2012) Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 120, e60-e722
32. Aoki, H., Hisada, T., Ishizuka, T., Utsugi, M., Kawata, T., Shimizu, Y., Okajima, F., Dobashi, K., and Mori, M. (2008) Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem. Biophys. Res. Commun. 367, 509-5155
33. Aoki, H., Hisada, T., Ishizuka, T., Utsugi, M., Ono, A., Koga, Y., Sunaga, N., Nakakura, T., Okajima, F., Dobashi, K., and Mori, M. (2010) Protective effect of resolvin E1 on the development of asthmatic airway inflammation. Biochem. Biophys. Res. Commun. 400, 128-1333
34. Haworth, O., Cernadas, M., Yang, R., Serhan, C. N., and Levy, B. D. (2008) Resolvin E1 regulates interleukin 23, interferongamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 9, 873-8799
35. Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C. H., Yang, R., Petasis, N. A., and Serhan, C. N. (2010) Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. U. S. A. 107, 1660-16655
36. Titos, E., Rius, B., Gonzalez-Periz, A., Lopez-Vicario, C., Moran- Salvador, E., Martinez-Clemente, M., Arroyo, V., and Claria, J. (2011) Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J. Immunol. 187, 5408-54188
37. Tian, H., Lu, Y., Sherwood, A. M., Hongqian, D., and Hong, S. (2009) Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. Invest. Ophthalmol. Vis. Sci. 50, 3613-36200
38. De Caterina, R., Cybulsky, M. A., Clinton, S. K., Gimbrone, M. A., Jr., and Libby, P. (1995) Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostaglandins Leukot. Essent. Fatty Acids 52, 191-1955
39. McMahon, B., Mitchell, D., Shattock, R., Martin, F., Brady, H. R., and Godson, C. (2002) Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J. 16, 1817-18199
40. McMahon, B., Stenson, C., McPhillips, F., Fanning, A., Brady, H. R., and Godson, C. (2000) Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. J. Biol. Chem. 275, 27566-275755
41. Mitchell, D., Rodgers, K., Hanly, J., McMahon, B., Brady, H. R., Martin, F., and Godson, C. (2004) Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells. Am. J. Pathol. 164, 937-9466
42. Rodgers, K., McMahon, B., Mitchell, D., Sadlier, D., and Godson, C. (2005) Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells. Am. J. Pathol. 167, 683-6944
43. Qu, X., Zhang, X., Yao, J., Song, J., Nikolic-Paterson, D. J., and Li, J. (2012) Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. [E-pub ahead of print] J. Pathol. doi: 10.1002/path.40500